Virtus Investment Advisers’s AbbVie ABBV Stock Holding History

Virtus Investment Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-44	Closed	-$7.82K	–	476
2024 Q4	$7.82K	Sell	44 -800	-95%	-$147K	0.01%	358
2024 Q3	$167K	Buy	+844	New	+$158K	0.13%	215
2024 Q2	–	Sell	-1,510	Closed	-$250K	–	138
2024 Q1	$275K	Buy	1,510 +970	+180%	+$167K	0.2%	136
2023 Q4	$83.7K	Buy	+540	New	+$78.7K	0.06%	254
2023 Q3	–	Sell	-1,145	Closed	-$154K	–	243
2023 Q2	$154K	Hold	1,145	–	–	0.1%	212
2023 Q1	$182K	Buy	+1,145	New	+$175K	0.13%	197
2018 Q1	–	Sell	-6,711	Closed	-$649K	–	10
2017 Q4	$649K	Sell	6,711 -338	-5%	-$31.9K	0.07%	264
2017 Q3	$626K	Sell	7,049 -749	-10%	-$57K	0.07%	281
2017 Q2	$565K	Sell	7,798 -1,643	-17%	-$110K	0.06%	311
2017 Q1	$615K	Buy	+9,441	New	+$594K	0.05%	301
2016 Q4	–	Sell	-34,637	Closed	-$2.19M	–	468
2016 Q3	$2.19M	Buy	+34,637	New	+$2.24M	0.14%	211

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Virtus Investment Advisers's ABBV Position: Q1 2025 in Review

Virtus Investment Advisers sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 44 shares — an estimated $7.82K sold.

Virtus Investment Advisers first reported a position in ABBV in Q3 2016 and held it in 11 quarters. The position peaked at $2.19M in Q3 2016. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Virtus Investment Advisers reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
Virtus Investment Advisers sold 44 AbbVie shares in Q1 2025, an estimated $7.82K.
Virtus Investment Advisers first reported a position in AbbVie in Q3 2016 and held it in 11 quarters.
Virtus Investment Advisers's AbbVie position peaked at $2.19M in Q3 2016.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.